30 /100
MEDIUM RISK
Score updated Apr 28, 2026

GLUE

Monte Rosa Therapeutics, Inc. — Stock Dilution Tracker

Track GLUE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track GLUE — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GLUE.
🔔 Track GLUE — Get forecast alerts →
💹 Market Data
Market Cap$1.51B
Shares Outstanding80.02M
Float57.20M
Cash$377.10M
Debt$39.19M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 6.9% shares (2025Q4 vs prior)
160 institutional holders · 65.85M shares
#1 NEA Management Company, LLC 7.69M shares
#2 PRICE T ROWE ASSOCIATES INC /MD/ 5.12M shares
#3 TCG Crossover Management, LLC 4.62M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest15.84M
Days to Cover16.0
% of Float27.7%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Jun 30, 2021
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track GLUE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLUE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GLUE
📊 GLUE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GLUE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.